CLINICAL

Antimicrobials approved for children’s skin infectionsFor the first time in a decade, there are antibiotics newly approved for use in children with skin and skin structure infections that do not respond to conventional treatment.
Oral baricitinib instead of topicals for atopic dermatitis?EADV study shows that this JAK inhibitor is a promising drug candidate in moderate-to-severe AD.
Guselkumab front and center at EADV Congress
Guselkumab front and center at EADV CongressIL-23 inhibitors represent one more very effective strategy for controlling psoriasis with PASI rates comparable to other biologics.
Atopic dermatitis associated with different bacteria depending on disease severityNIH investigators find that Staphylococcus epidermidis is predominant in less severe cases, while Staphylococcus aureus is associated with patients who have more severe disease.
Ingredients in eczema topicals pose contact dermatitis riskIngredients used in topical products used to relieve atopic dermatitis in children might put those patients at higher risk for contact dermatitis.
Asthma and food allergies associated with early-onset ADChildren with early-onset atopic dermatitis (AD) have an increased risk of developing asthma and food allergies by age 6 years, especially those with persistent dermatitis symptoms.
Use common sense for dermatologic concernsDr Farber shares 8 common sense tips for handling dermatologic concerns.
New guidelines: Screening for pediatric psoriasis comorbiditiesRecommendations emphasize early detection of risks for medical comorbidities later in life.
Psoriasis and atopic dermatitis respond to IL-17 creamNitric oxide-releasing cream that targets IL-17 moving toward clinical trials.
Relief from the itch in atopic dermatitisAn experimental drug designed to control itching in people with moderate-to-severe AD shows promise in early trial.

Poll

View Results